✦ LIBER ✦

PCV47 Economic Evaluation of Dabigatran for Stroke Prevention Among Patients With Atrial Fibrillation in the Netherlands

✍ Scribed by H.H. Le; P. Pechlivanoglou; P.M. Engelfriet; M.J. Postma; W.K. Redekop

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV49 Economic Evaluation of Rivaroxaban

✍ G. Kourlaba; N. Maniadakis; G. Andrikopoulos; P. Vardas; A. Llyod; Y. Asukai; T. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Dabigatran for Stroke Prevention in All

✍ Jonathan E. Hunchuck; Jennifer D. Lake 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Dabigatran efficacy-safety assessment fo

✍ J. W. EIKELBOOM; D. J. QUINLAN; S. J. CONNOLLY; R. G. HART; S. YUSUF 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

PCV60 Cost-Effectiveness of Dabigatran f

✍ D. Tilden; P. Germanos; J. Gordon; L. Tocchini; B. Monz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Dabigatran and Factor Xa Inhibitors for

✍ Shinichiro Uchiyama; Setsuro Ibayashi; Masayasu Matsumoto; Takehiko Nagao; Ken N 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 635 KB

PCV25 RISK OF STROKE AND PREVENTATIVE ST

✍ S Gupta; A Goren; D Freedman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB